We used a high dose to block all the A2A receptors, however, previous studies have demonstrated that lower doses (~0.01 mg/kg) of A2A antagonists had a protective effect in several ischemia models, and high doses of A2A antagonist were less selective for A2A receptors. The gene discussed is IGKV2D-29; the disease is ischemia.